Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yuankeng, Huang"'
Autor:
Jianmin Guo1,2,3, Yuankeng Huang1,3, Xialing Lei1,3, Yinghua Deng1, Xiaoying Li1, Wenqiang Zhang1, Wenpei Chen1,3, Feibiao Meng1, Wei Yang1,2,3 ywdoccn@163.com
Publikováno v:
Tropical Journal of Pharmaceutical Research. Jan2023, Vol. 22 Issue 1, p105-112. 8p.
Autor:
Qinhai Ma, Runfeng Li, Jianmin Guo, Man Li, Lin Ma, Jun Dai, Yongxia Shi, Jinlong Dai, Yuankeng Huang, Cailing Dai, Weiqi Pan, Huiling Zhong, Hong Zhang, Jian Wen, Haoting Zhao, Linping Wu, Wei Yang, Biliang Zhang, Zifeng Yang
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1698 (2022)
There is an urgent need for a broad-spectrum and protective vaccine due to the emergence and rapid spreading of more contagious SARS-CoV-2 strains. We report the development of RBMRNA-176, a pseudouridine (Ψ) nucleoside-modified mRNA-LNP vaccine enc
Externí odkaz:
https://doaj.org/article/0905cf7c270e49ba8c7238e8eef07b74
Autor:
Xiaofei Wang, Jianmin Guo, Xinyu Deng, Yuankeng Huang, Caiguo Ye, Huiqing Liang, Junhua Rao, Wei Yang
Publikováno v:
Acta Cirúrgica Brasileira, Vol 33, Iss 8, Pp 690-702 (2018)
Abstract Purpose: To evaluate the toxicity of Erbitux as well as its biosimilar APZ001 antibody (APZ001) in pre-clinical animal models including mice, rabbits and cynomolgus monkeys. Methods: We performed analysis of normal behavior activity, autonom
Externí odkaz:
https://doaj.org/article/b28e2bc212b0422e8796c4b1f0215cd1
Autor:
Feibiao Meng, Chun Liang, Jianmin Guo, Zhong Han, Yuankeng Huang, Xialing Lei, Richou Han, Haifeng Liao, Wei Yang, Yinghua Deng
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Introduction. Forsythin is the main ingredient of Forsythia suspensa and is widely used in treatment of fever, viral cold, gonorrhea, and ulcers clinically. This study aimed to evaluate the potential genetic toxicity of forsythin and its safety for h
Autor:
Yuankeng Huang, Wang Xiaofei, Wei Yang, Caiguo Ye, Jianmin Guo, Deng Xinyu, Huiqing Liang, Junhua Rao
Publikováno v:
Acta Cirurgica Brasileira, Vol 33, Iss 8, Pp 690-702 (2018)
Acta Cirúrgica Brasileira v.33 n.8 2018
Acta Cirúrgica Brasileira
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
instacron:SBDPC
Acta Cirurgica Brasileira, Volume: 33, Issue: 8, Pages: 690-702, Published: AUG 2018
Acta Cirúrgica Brasileira v.33 n.8 2018
Acta Cirúrgica Brasileira
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
instacron:SBDPC
Acta Cirurgica Brasileira, Volume: 33, Issue: 8, Pages: 690-702, Published: AUG 2018
Purpose: To evaluate the toxicity of Erbitux as well as its biosimilar APZ001 antibody (APZ001) in pre-clinical animal models including mice, rabbits and cynomolgus monkeys. Methods: We performed analysis of normal behavior activity, autonomic and no
Autor:
Jianmin, Guo, Yuankeng, Huang, Xialing, Lei, Hong, Zhang, Baiquan, Xiao, Zhong, Han, Chun, Liang, Wei, Yang
Publikováno v:
Annals of clinical and laboratory science. 49(1)
To study the mechanism of reproductive systemic toxicity ofThe SD rats were randomly divided into groups and allocated three different treatments: control, 37.8 mg/kg Tripterygium glycosides, and 94.5 mg/kg Tripterygium glycosides, with each treatmen
Autor:
Xialing Lei, Yuankeng Huang, Caiguo Ye, Wang Xiaofei, Wei Yang, Huiqing Liang, Deng Xinyu, Jianmin Guo
Publikováno v:
Tropical Journal of Pharmaceutical Research. 17:1885
Purpose: To compare the pharmacokinetics of APZ001 antibody with those of cetuximab (Erbitux®) and to evaluate the toxicology of the former. Methods: To evaluate cetuximab’s biosimilar APZ001, Crl:CD1(ICR) (CD-1) mice and Macaca fascicularis (cyno